Article

Genetic factors in cardiovascular disease. 10 questions.

Department of Medicine, University of California, Los Angeles, CA 90095-1679, USA.
Trends in Cardiovascular Medicine (Impact Factor: 2.07). 12/2003; 13(8):309-16. DOI: 10.1016/j.tcm.2003.08.001
Source: PubMed

ABSTRACT The common forms of cardiovascular disease (CVD) have a complex etiology, involving multiple genetic influences and important environmental interactions. Because of this complexity, it has proved difficult to apply the positional cloning approaches that have revolutionized understanding of Mendelian (single-gene) disorders; and the understanding of the genetics of CVD and its underlying cause, atherosclerosis, remains poor. This review, organized into 10 broad questions, summarizes the understanding of the genetics of common, complex forms of CVD. Implications for DNA-based diagnosis, pharmacogenetics, and risk assessment are also discussed.

0 Followers
 · 
61 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: RESUMEN Las enfermedades comunes, como la diabetes o las enfermedades cardio-vasculares, tienen un importante componente genético. El conocimiento de las variantes génicas que las causan es esencial para el diseño de futuras herra-mientas diagnósticas. Mientras que las mutaciones localizadas en las regiones codificantes tienen una elevada penetrancia y no pueden explicar la genética de las enfermedades comunes, las variantes en las regiones reguladoras tienen una serie de propie-dades que las hacen ideales para hacerlo. En primer lugar, presentan una pene-trancia baja. Además, poseen una mayor capacidad de interaccionar con los cam-bios ambientales. La existencia de un gran número de polimorfismos en las regiones regulado-ras hace necesario implementar estrategias lo más económicas posibles para su identificación y caracterización. La selección de genes candidatos, seguida de aná-lisis bioinformáticos, es una de ellas. Pero el análisis sería incompleto sin la rea-lización de ensayos funcionales cuyos métodos se describen en este capítulo. Los más habituales son el retardo en gel y los ensayos con genes reporteros, una de cuyas principales limitaciones es la imposibilidad de llevarlos a cabo en gran es-cala. Por esta razón se están diseñando nuevas aproximaciones con este objetivo. La combinación de todos ellos ya ha producido resultados interesantes. Es de es-perar que en los próximos años se produzca un desarrollo que permita la aplica-ción a gran escala y que permita desarrollar algoritmos que sirvan como pruebas para diagnosticar el riesgo de padecer las enfermedades más comunes.
  • [Show abstract] [Hide abstract]
    ABSTRACT: For classic “Mendelian” genetic diseases, a single gene is responsible. A rare mutation in that gene causes a dramatic change in protein concentration or function that is both necessary and sufficient to cause the disease, and environmental factors play a small or nonexistent role. Examples in cardiology include familial hypercholesterolemia, familial hypertrophic cardiomyopathy, Marfan syndrome, and congenital long QT syndrome. By contrast, for complex genetic diseases, multiple genes are involved and environmental factors play a large role. Variants in any single gene therefore tend to be associated with far more modest effects and are neither necessary nor sufficient to cause the disease. The genetic variants responsible for these modest effects tend to be more common (>1% prevalence) and, by convention, are called polymorphisms, rather than mutations. Most of the common diseases in cardiology fall into this category, including hypertension, atrial fibrillation, and coronary heart disease (CHD). Currently, no genetic markers are ready for widespread adoption as risk factors for CHD. Yet, there are several promising, biologically plausible candidates. Researchers are now designing larger and better studies in order to maximize the chances of detecting subtle but likely important contributors to CHD.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The main aim of this article is to provide clinicians with the basic knowledge needed to interpret data on genetic disorders that may be relevant to clinical decision-making. The human genome is likened to an encyclopedia, “The encyclopedia of life”, which is used to explain how genetic information is transmitted and to describe the causes and consequences of mutations, along with the main rules used for naming them. There follows a discussion of which mutations can contribute to the development of cardiovascular disease and how they do so. Finally, there is a description of how genetics has contributed to improvements in the diagnosis and treatment of familial hypercholesterolemia, one of the conditions in which lipid-lowering therapy is efficacious and cost-effective. In addition, there is an explanation of how large-scale genetic assays, such as biochips, are used for detecting the principle mutations found in the genes responsible for familial hypercholesterolemia.
    Revista Española de Cardiología Suplementos 01/2009; 9(2). DOI:10.1016/S1131-3587(09)71501-8